25 Top Lowest PE Ratios in the S&P 500
By The Online Investor Staff, updated Sat., Mar. 25, 12:13 PM
This Slide: #1 of 25 |
#25. Moderna Inc (NASDAQ:MRNA) — PE Ratio: 5.33
Moderna is a biotechnology company focusing on messenger RNA (mRNA) therapeutics and vaccines to create medicines. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of diseases. Co. is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune diseases and cardiovascular diseases. Co. has a collaboration agreement with the Institute of Life Changing Medicines to develop a mRNA therapeutic (mRNA-3351) for Crigler-Najjar Syndrome Type 1.
MRNA SEC Filing Email Alerts ServiceOpen the MRNA Page at The Online Investor »
|
Open the MRNA Page at The Online Investor (in a new window) »
List of Low PE Ratio Stocks in this Slideshow: Company Ticker PE Ratio First Republic Bank (San Francisco, CA) FRC 1.61 DISH Network Corp DISH 2.42 APA Corp APA 3.13 American International Group Inc AIG 3.64 Principal Financial Group Inc PFG 3.80 Phillips 66 PSX 4.03 Organon & Co OGN 4.12 Zions Bancorporation, N.A. ZION 4.16 Mosaic Co (The) MOS 4.21 Marathon Oil Corp. MRO 4.21 CF Industries Holdings Inc CF 4.23 Citigroup Inc C 4.25 Valero Energy Corp VLO 4.45 Synchrony Financial SYF 4.56 Coterra Energy Inc CTRA 4.66 Comerica, Inc. CMA 4.77 Capital One Financial Corp COF 5.05 Diamondback Energy, Inc. FANG 5.10 Devon Energy Corp. DVN 5.11 PulteGroup Inc PHM 5.15 Nucor Corp. NUE 5.16 Steel Dynamics Inc. STLD 5.18 Discover Financial Services DFS 5.21 Goldman Sachs Group Inc GS 5.26 Moderna Inc MRNA 5.33
![]() ![]() Get SEC Filing Alerts Get Dividend Alerts ![]() ![]() |
![]() Buy (2.93 out of 4) 21st percentile
(ranked lower than approx. 79% of all stocks covered)
Analysts' Target Price: MRNA Stock Forecast Based on Zacks ABR data; powered by Xignite ![]() |
